Resident Company News

- Cologuard test volume increased 64 percent, with approximately 934,000 tests completed in 2018 - Nearly 15,000 health care providers ordered their first Cologuard test during the fourth quarter - We expect approximately 94 percent of patients who completed a Cologuard test during the fourth quarter to...

Fujifilm Cellular Dynamics, Inc. (FCDI) plans to build a $21 million facility in Madison to manufacture stem cells for use in developing regenerative medicine drugs -- its own drugs and those of other companies. FCDI, formerly Cellular Dynamics International, manufactures human induced pluripotent stem cells (iPSCs),...

Talking the cost of doing business in Wisconsin with Tom Still, President of The WI Technology Council, who says there is reason to be optimistic. Also find out about the WI Governors Business Plan Contest. Great conversation about Wisconsin's technology economic impact and future opportunities. Click image...

Stemina Biomarker Discovery’s roots are in stem cells, one of the pillars of Madison’s standing in the bioscience world. After eight years as general counsel and director of business development for the Wisconsin Alumni Research Foundation, or WARF, Beth Donley founded Stemina in 2006 with...

Exact Sciences Corp. is looking at two new targets for cancer screening: blood cancers and melanoma. The company also has begun a study to see if its flagship product, the Cologuard stool test for colorectal cancer, is as good at finding the illness in younger people,...

When one releases a breath, not much thought is given to the information being whisked away. With that rhythmic breath, an individual is exhaling a map to a healthier lifestyle -- something to be navigated by entrepreneur Joe Kremer. SmartBurn is a patent-pending technology that identifies...

Semba Biosciences, a Madison company that makes purifying equipment used by life sciences companies, is getting a $3 million investment from Tosoh Bioscience, part of a Japanese conglomerate, in a move that’s expected to lead to Tosoh’s eventual purchase of Semba. Founded in 2005, Semba’s Octave...

In this groundbreaking talk Ayla Annac, CEO of Invivo Sciences discusses how micro human-hearts are pioneering life saving drug discovery and diagnostics for heart diseases, cancer treatments and rare diseases. Ayla is a co-founder of InvivoSciences, Inc., which has pioneered the development of ‘human micro...

Loading new posts...
No more posts